Scholarlink

Background <p>Early cancer diagnosis is crucial in improving the survival. The main goal in NHS in cancer diagnosis is detection rate of 75% by 2028. Our study presents the economic analysis of impact of early versus late-cancer diagnosis on healthcare resources use and costs within our Trust also exploring the influence of deprivation index.</p> Methods <p>We retrospectively analyse the cost-of-care and patient-level data for 4596 patients across nine cancer groups who fully completed their cancer pathway between April 2020 and September 2024. Costs were compared between early (stage 1 and 2) versus late (stage 3 and 4) diagnosis.</p> Results <p>Significant variations in costs were determine across cancer types, with colorectal and haematological malignancies being most costly. Early-stage diagnosis averaged £11,2K, significantly lower than late- stage £23,8K with largest differences seen in haematological, colorectal and breast cancers. A hypothetical 75% early detection rate could save the trust £14.7 million over four years. Successful treatment yielded an average 10.74 years of healthy life expectancy, further increased by early detection.</p> Conclusions <p>Late cancer diagnosis dramatically increases healthcare costs underscoring the importance of early detection and advanced screening methods. Extrapolating a 75% early detection rate across the NHS could yield substantial financial savings, highlighting its impact on healthcare efficiency.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The crucial role of early diagnosis for patients and the nation, understanding the costs of late-stage cancer diagnosis from a large district general hospital in England

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月28日

查看全文
  • Valentin Butnari,
  • Petra Scantlebury,
  • Tony Green,
  • Devendra Pattni,
  • Ahmer Mansuri,
  • Wendy Chinnery,
  • Nirooshun Rajendran,
  • Mike Brannan,
  • Matthew Cole,
  • Saswata Banerjee

摘要

Background

Early cancer diagnosis is crucial in improving the survival. The main goal in NHS in cancer diagnosis is detection rate of 75% by 2028. Our study presents the economic analysis of impact of early versus late-cancer diagnosis on healthcare resources use and costs within our Trust also exploring the influence of deprivation index.

Methods

We retrospectively analyse the cost-of-care and patient-level data for 4596 patients across nine cancer groups who fully completed their cancer pathway between April 2020 and September 2024. Costs were compared between early (stage 1 and 2) versus late (stage 3 and 4) diagnosis.

Results

Significant variations in costs were determine across cancer types, with colorectal and haematological malignancies being most costly. Early-stage diagnosis averaged £11,2K, significantly lower than late- stage £23,8K with largest differences seen in haematological, colorectal and breast cancers. A hypothetical 75% early detection rate could save the trust £14.7 million over four years. Successful treatment yielded an average 10.74 years of healthy life expectancy, further increased by early detection.

Conclusions

Late cancer diagnosis dramatically increases healthcare costs underscoring the importance of early detection and advanced screening methods. Extrapolating a 75% early detection rate across the NHS could yield substantial financial savings, highlighting its impact on healthcare efficiency.